Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more

The Importance of Real-World Evidence in Medical Research and Drug Development

The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its growing importance and vast potential to improve personalized medicine, overall healthcare outcomes, and eventually democratization of scientific facts by general accessibility.

Inhaled Antibody Therapy for RSV Moving Forward

Inhalon plans to begin a human challenge for their inhaled antibody therapy study in 2026.

How AI Can Protect Vital Pipelines and Cables Deep in the Ocean

Militaries and startups use artificial intelligence to sift through vast amounts of data and power autonomous underwater vehicles, boosting efforts to surveil the seabed.

Rap Icon Nelly Joins the Kinexions 2025 Lineup

Kinaxis® announced that Nelly will be headlining the entertainment stage at Kinexions 2025, its annual supply chain community conference taking place in Austin, Texas from March 31 to April 2.

Virax Biolabs on LinkedIn

CEO James Foster shares insights on navigating global launch strategies amid political uncertainty. From adapting to tariffs to leveraging AI tools like ChatGPT for research, we’re staying nimble and ahead of the game.

Check out the interview with Pharmaceutical Executive. here: https://lnkd.in/eYT9Yt6N

#vrax #Biotech #Innovation #Leadership #GlobalStrategy #AI

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs